Would like to know the separate extended life expectancy and QOL data for the 24 patients in the 1200 mg cohort.
At a pure guess, median OS for this group ought to lie somewhere between 22 to 23 months.
Presentation at ASCO will hopefully touch on this.
I like RBx's comment earlier in the day. Hard to think that Novartis would not see some dollar signs.
closest to the pin , tomorrow and month end, page-6
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 12000 | 1 |
View Market Depth
| Last trade - 16.12pm 17/07/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable